McMaster University

McMaster University

Andrew Don-Wauchope

MB.BCh, MD, FRCP Edin, FCPath, FRCPath

Pathology and Molecular Medicine

Division: Clinical Pathology

Associate Member Department of Medicine (Endocrinology)

Vice President Clinical Services
LifeLabs, 100 International Blvd
Toronto, ON M9W 6J6

photo of Dr Don Wauchope

Faculty Biography

Education and Professional Standing

FRCP Edin, Royal College of Physicians of Edinburgh, 2009
FRCPath, Royal College of Pathologists, 2008
FCPath (Chem), South African College of Medicine, 2005
MD, University of Edinburgh, Scotland, 2005
BSc Med (Hons) Epidemiology and Biostatistics, University of Cape Town, South Africa, 1994
MB.BCh, University of Witwatersrand, South Africa, 1990


Research Focus

Utilization of Laboratory Diagnostic Tests

The need to evaluate the evidence base for the use of diagnostic tests in clinical laboratory medicine is essential to the future use of laboratory tests. The practical utilisation of tests is another important area that requires investigation. Research activities that allow evidence based application of laboratory testing are under development.

Clinical Focus

Dr. Don-Wauchope has clinics at Hamilton Health Sciences where he consults patients referred with Lipid disorders. The use of laboratory diagnostics in clinical endocrinology is a particular specialised area of interest. He is also involved with the Choosing Wisely Canada campaign.

Academic Interests

Dr. Don-Wauchope teaches in the residency training program, training post-graduate medical biochemistry residents and fellows, general pathology residents and endocrinology fellows.


Selected Publications

  • Simons JE, Don-Wauchope AC. Evaluation of Natriuretic Peptide recommendations in Heart Failure Clinical Practice Guidelines. Clinical Biochemistry. 2016 Jan; 49(1): 8-15.
  • Rehan M, Raizman J, Cavlier E, Don-Wauchope AC, Holmes DT. Laboratory Challenges in Primary Aldosteronism Screening and Diagnosis. Clin Biochem. 2015 Apr;48(6):377-87. 
  • Balion C, Don-Wauchope A, Hill S, Santaguida PL, Booth R, Brown JA, Oremus M, Ali U, Bustamam A, Sohel N, McKelvie R, Raina P. Use of Natriuretic Peptide Measurement in the Management of Heart Failure. Comparative Effectiveness Review No. 126. AHRQ Publication No. 13(14)-EHC118-EF. Rockville, MD:Agency for Healthcare Research and Quality; November 2013.
  • Don-Wauchope AC, Sievenpiper JL, Hill SA, Iorio A. Applicability of the AGREE II instrument in evaluating the development process and quality of current National Academy of Clinical Biochemistry guidelines. Clin Chem. 2012 Oct;58(10):1426-37.
  • Veljkovic K, Servedio D, Don-Wauchope AC. Reporting of post-PEG prolactin: precipitation by polyethylene glycol 6000 or  polyethylene glycol 8000 will change reference intervals for monomeric prolactin. Annals of Clinical Biochemistry 2012 Jul;49(Pt 4):402-4.
  • Huang Y, Don-Wauchope AC . The Clinical Utility of Kidney Injury Molecule 1 in the Prediction, Diagnosis and Prognosis of Acute Kidney Injury: A Systematic Review. Inflamm Allergy Drug Targets. 2011; 10: 260-271. May 2011.

Pubmed link to bibliography

Valid XHTML 1.0 Transitional Level Double-A conformance, W3C WAI Web Content Accessibility Guidelines 2.0